Back Bay Life Science Advisors
Market Insights
Investment Banking Analytics Strategic Advisory
Company Global Partnerships Meet Our Team Careers Resource Library Locations
DNB//Back Bay Partnership DNB//Back Bay Healthcare Team
Corporate Contact Toronto Office
OUR SERVICES Investment Banking Analytics Strategic Advisory About Company Global Partnerships Meet Our Team Careers Resource Library Locations Market Insights DNB//BACK BAY DNB//Back Bay Partnership DNB//Back Bay Healthcare Team Contact Corporate Contact Toronto Office
Back Bay Life Science Advisors

DNB//BACK BAY Weekly Market Updates

Market Update for Week of June 20, 2025

Market Update for Week of June 20, 2025

The Week at a Glance:

Markets Finish Flat: The three major US indices traded sideways during the week as investors digested continued geopolitical tensions between Israel and Iran, along with the Federal Reserve’s decision to not cut rates

Lilly’s Buying Spree: Just three weeks after Lilly paid $1.0B to acquire SiteOne Therapeutics, Eli Lilly has made headlines again through the acquisition of the gene editing and cardiovascular disease focused Verve Therapeutics for up to $1.3B

IPOs Continue to Favor Commercial Stage: Caris Life Sciences, a developer of AI-based genomics technology for diagnosis, raised an oversubscribed $494.1M IPO, marking the second largest healthcare IPO YTD and the 11th commercial IPO (out of 17 IPOs total)

READ FULL UPDATE >

1
Previous Next
Market Update for Week of June 20, 2025
 

545 Boylston Street
12th Floor
Boston, MA 02116

+1 617.236.0954 Office
+1 617.236.1215 Fax

Boston | Toronto

 

OUR SERVICES


STRATEGIC ADVISORY >>

  • Life sciences corporate growth and market access strategy

  • Franchise, business unit & therapeutic area strategy

  • Competitive intelligence

  • Asset & development prioritization

  • Platform implementation

  • Payor/Pricing strategy

  • Contracting strategy

  • Launch & counter-launch strategy

  • Product positioning, branding & messaging

  • Life-cycle management

  • Corporate growth strategy

  • Liquidity & exit planning

INVESTMENT BANKING >>

FINANCING >>

  • Mergers, acquisitions & divestitures

  • IPO preparedness and execution

  • Private & public company, cross-border execution

  • Financing support

  • Fairness opinion, valuation

  • Treasury solutions

  • Fixed income origination

  • Equity and debt capital markets

  • Liquidity and exit planning

  • Due diligence and valuation

  • Divestments

  • Licensing (buy and sell side)

  • Partnering

  • Recapitalization

  • New Company formation

  • Investment Grade Bonds

  • High yield and convertible bonds

  • Debt and restructuring

Subscribe

Sign up with your email address to receive weekly market updates.

We respect your privacy.

Thank you for subscribing.


©2025 Back Bay Life Science Advisors | Privacy Policy